{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:19:30Z","timestamp":1787505570677,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,16]]},"DOI":"10.7759\/cureus.43559","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T05:36:09Z","timestamp":1692164169000},"source":"Crossref","is-referenced-by-count":5,"title":["The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Majed","family":"Aleissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor MS","year":"2021","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021, 20:3759-81. 10.1111\/jocd.14537","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.77510","article-title":"Androgenetic alopecia: quality-of-life and associated lifestyle patterns","volume":"2","author":"Sawant N","year":"2010","unstructured":"Sawant N, Chikhalkar S, Mehta V, Ravi M, Madke B, Khopkar U. Androgenetic alopecia: quality-of-life and associated lifestyle patterns. Int J Trichology. 2010, 2:81-5. 10.4103\/0974-7753.77510","journal-title":"Int J Trichology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1741037","article-title":"Psychology of hair loss patients and importance of counseling","volume":"54","author":"Dhami L","year":"2021","unstructured":"Dhami L. Psychology of hair loss patients and importance of counseling. Indian J Plast Surg. 2021, 54:411-5. 10.1055\/s-0041-1741037","journal-title":"Indian J Plast Surg"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair R","year":"2005","unstructured":"Sinclair R, Wewerinke M, Joolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005, 152:466-473.","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.905140","article-title":"Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial","volume":"9","author":"Liang X","year":"2022","unstructured":"Liang X, Chang Y, Wu H, Liu Y, Zhao J, Wang L, Zhuo F. Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial. Front Med (Lausanne). 2022, 9:905140. 10.3389\/fmed.2022.905140","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117426","article-title":"Female pattern hair loss","volume":"45","author":"Olsen EA","year":"2001","unstructured":"Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001, 45:S70-80. 10.1067\/mjd.2001.117426","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Peterson J","year":"2011","unstructured":"Peterson J, Welch V, Losos M, et al.. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa; 2011."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref9","article-title":"Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives","volume":"3","author":"Lin L","year":"2020","unstructured":"Lin L, Xu C. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep. 2020, 3:178.","journal-title":"Health Sci Rep"},{"key":"ref10","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","author":"Higgins JPT","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA.  Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). 2022 (ed): John Wiley & Sons, Chichester;"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224362","article-title":"Implementation and effectiveness of non-specialist mediated interventions for children with autism spectrum disorder: a systematic review and meta-analysis","volume":"14","author":"Naveed S","year":"2019","unstructured":"Naveed S, Waqas A, Amray AN, et al.. Implementation and effectiveness of non-specialist mediated interventions for children with autism spectrum disorder: a systematic review and meta-analysis. PLoS One. 2019, 14:e0224362. 10.1371\/journal.pone.0224362","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair R","year":"2005","unstructured":"Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005, 152:466-73. 10.1111\/j.1365-2133.2005.06218.x","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair RD","year":"2018","unstructured":"Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018, 57:104-9. 10.1111\/ijd.13838","journal-title":"Int J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"Burns LJ","year":"2020","unstructured":"Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol. 2020, 83:276-8. 10.1016\/j.jaad.2020.03.087","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.063","article-title":"Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy","volume":"73","author":"Famenini S","year":"2015","unstructured":"Famenini S, Slaught C, Duan L, Goh C. Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. J Am Acad Dermatol. 2015, 73:705-6. 10.1016\/j.jaad.2015.06.063","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S398950","article-title":"The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review","volume":"16","author":"Wang C","year":"2023","unstructured":"Wang C, Du Y, Bi L, Lin X, Zhao M, Fan W. The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review. Clin Cosmet Investig Dermatol. 2023, 16:603-12. 10.2147\/CCID.S398950","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2007.00332.x","article-title":"Treatment of female pattern hair loss with a combination of spironolactone and minoxidil","volume":"48","author":"Hoedemaker C","year":"2007","unstructured":"Hoedemaker C, van Egmond S, Sinclair R. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. Australas J Dermatol. 2007, 48:43-5. 10.1111\/j.1440-0960.2007.00332.x","journal-title":"Australas J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.10.097","article-title":"Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls","volume":"84","author":"Olamiju B","year":"2021","unstructured":"Olamiju B, Craiglow BG. Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls. J Am Acad Dermatol. 2021, 84:1689-91. 10.1016\/j.jaad.2020.10.097","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/166490-the-efficacy-and-safety-of-oral-spironolactone-in-the-treatment-of-female-pattern-hair-loss-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:03:58Z","timestamp":1707491038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/166490-the-efficacy-and-safety-of-oral-spironolactone-in-the-treatment-of-female-pattern-hair-loss-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.43559","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}